Literature DB >> 25070413

A 21st century roadmap for human health risk assessment.

Timothy P Pastoor1, Ammie N Bachman, David R Bell, Samuel M Cohen, Michael Dellarco, Ian C Dewhurst, John E Doe, Nancy G Doerrer, Michelle R Embry, Ronald N Hines, Angelo Moretto, Richard D Phillips, J Craig Rowlands, Jennifer Y Tanir, Douglas C Wolf, Alan R Boobis.   

Abstract

The Health and Environmental Sciences Institute (HESI)-coordinated Risk Assessment in the 21st Century (RISK21) project was initiated to develop a scientific, transparent, and efficient approach to the evolving world of human health risk assessment, and involved over 120 participants from 12 countries, 15 government institutions, 20 universities, 2 non-governmental organizations, and 12 corporations. This paper provides a brief overview of the tiered RISK21 framework called the roadmap and risk visualization matrix, and articulates the core principles derived by RISK21 participants that guided its development. Subsequent papers describe the roadmap and matrix in greater detail. RISK21 principles include focusing on problem formulation, utilizing existing information, starting with exposure assessment (rather than toxicity), and using a tiered process for data development. Bringing estimates of exposure and toxicity together on a two-dimensional matrix provides a clear rendition of human safety and risk. The value of the roadmap is its capacity to chronicle the stepwise acquisition of scientific information and display it in a clear and concise fashion. Furthermore, the tiered approach and transparent display of information will contribute to greater efficiencies by calling for data only as needed (enough precision to make a decision), thus conserving animals and other resources.

Entities:  

Keywords:  exposure; framework; hazard; problem formulation; risk; risk assessment; risk policy; tiered

Mesh:

Year:  2014        PMID: 25070413     DOI: 10.3109/10408444.2014.931923

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  27 in total

1.  Determination of chemical-disease risk values to prioritize connections between environmental factors, genetic variants, and human diseases.

Authors:  Marissa B Kosnik; David M Reif
Journal:  Toxicol Appl Pharmacol       Date:  2019-07-16       Impact factor: 4.219

2.  A Case Study Application of the Aggregate Exposure Pathway (AEP) and Adverse Outcome Pathway (AOP) Frameworks to Facilitate the Integration of Human Health and Ecological End Points for Cumulative Risk Assessment (CRA).

Authors:  David E Hines; Stephen W Edwards; Rory B Conolly; Annie M Jarabek
Journal:  Environ Sci Technol       Date:  2017-12-29       Impact factor: 9.028

3.  Aggregate Exposure Pathways in Support of Risk Assessment.

Authors:  Yu-Mei Tan; Jeremy A Leonard; Stephen Edwards; Justin Teeguarden; Alicia Paini; Peter Egeghy
Journal:  Curr Opin Toxicol       Date:  2018-03-29

4.  Conceptual Framework To Extend Life Cycle Assessment Using Near-Field Human Exposure Modeling and High-Throughput Tools for Chemicals.

Authors:  Susan A Csiszar; David E Meyer; Kathie L Dionisio; Peter Egeghy; Kristin K Isaacs; Paul S Price; Kelly A Scanlon; Yu-Mei Tan; Kent Thomas; Daniel Vallero; Jane C Bare
Journal:  Environ Sci Technol       Date:  2016-10-18       Impact factor: 9.028

5.  APROBA-Plus: A probabilistic tool to evaluate and express uncertainty in hazard characterization and exposure assessment of substances.

Authors:  Bas G H Bokkers; Marcel J Mengelers; Martine I Bakker; Weihsueh A Chiu; Wout Slob
Journal:  Food Chem Toxicol       Date:  2017-10-23       Impact factor: 6.023

Review 6.  Use of the RISK21 roadmap and matrix: human health risk assessment of the use of a pyrethroid in bed netting.

Authors:  John E Doe; Deborah R Lander; Nancy G Doerrer; Nina Heard; Ronald N Hines; Anna B Lowit; Timothy Pastoor; Richard D Phillips; Dana Sargent; James H Sherman; Jennifer Young Tanir; Michelle R Embry
Journal:  Crit Rev Toxicol       Date:  2015-10-30       Impact factor: 5.635

7.  Probabilistic modelling of prospective environmental concentrations of gold nanoparticles from medical applications as a basis for risk assessment.

Authors:  Indrani Mahapatra; Tian Yin Sun; Julian R A Clark; Peter J Dobson; Konrad Hungerbuehler; Richard Owen; Bernd Nowack; Jamie Lead
Journal:  J Nanobiotechnology       Date:  2015-12-22       Impact factor: 10.435

8.  Concentration of Zearalenone, Alpha-Zearalenol and Beta-Zearalenol in the Myocardium and the Results of Isometric Analyses of the Coronary Artery in Prepubertal Gilts.

Authors:  Magdalena Gajęcka; Michał S Majewski; Łukasz Zielonka; Waldemar Grzegorzewski; Ewa Onyszek; Sylwia Lisieska-Żołnierczyk; Jerzy Juśkiewicz; Andrzej Babuchowski; Maciej T Gajęcki
Journal:  Toxins (Basel)       Date:  2021-06-02       Impact factor: 4.546

9.  Correlations between Low Doses of Zearalenone, Its Carryover Factor and Estrogen Receptor Expression in Different Segments of the Intestines in Pre-Pubertal Gilts-A Study Protocol.

Authors:  Magdalena Gajęcka; Magdalena Mróz; Paweł Brzuzan; Ewa Onyszek; Łukasz Zielonka; Karolina Lipczyńska-Ilczuk; Katarzyna E Przybyłowicz; Andrzej Babuchowski; Maciej T Gajęcki
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

Review 10.  Exploring Global Exposure Factors Resources for Use in Consumer Exposure Assessments.

Authors:  Rosemary T Zaleski; Peter P Egeghy; Pertti J Hakkinen
Journal:  Int J Environ Res Public Health       Date:  2016-07-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.